Efficacy of Maraviroc in Modulating Atherosclerosis in HIV Patients.

Summary

The investigator tested the efficacy of maraviroc intensification on down-regulating atherosclerotic progression in HIV infected patients with optimal viro-immunologic control and at high cardiovascular risk.

Timeline

Start

2015-01-01

Primary completion

2017-04-30

Completion

2017-09-30

Drugs

Indications